Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy.
In recent years, tyrosine kinases (TKs) have been recognized as central players and regulators of cancer cell proliferation, apoptosis, and angiogenesis, and are therefore considered suitable potential targets for anti-cancer therapies. Several strategies for targeting TKs have been developed, the most successful being monoclonal antibodies and small molecule tyrosine kinase inhibitors. However, increasing evidence of acquired resistance to these drugs has been documented, and extensive preclinical studies are ongoing to try to understand the molecular mechanisms by which cancer cells are able to bypass their inhibitory activity.This review intends to present the most recently identified molecular mechanisms that mediate acquired resistance to tyrosine kinase inhibitors, identified through the use of in vitro models or the analysis of patient samples. The knowledge obtained from these studies will help to design better therapies that prevent and overcome resistance to treatment in cancer patients.
Sierra
J Rafael
JR
Institute for Cancer Research and Treatment, University of Torino Medical School, 10060 Candiolo (Torino), Italy.
Cepero
Virna
V
Giordano
Silvia
S
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*
D000970:Antineoplastic Agents; D011505:Protein-Tyrosine Kinases
Cancer Chemother Pharmacol. 2009 Oct;64(5):961-9
19255759
Oncogene. 2007 Jun 7;26(27):3909-19
17325667
Hematology Am Soc Hematol Educ Program. 2007;:376-83
18024654
Mol Cancer Ther. 2008 Nov;7(11):3499-508
18974395
Trends Genet. 2000 Aug;16(8):368
10904266
J Biol Chem. 1998 May 1;273(18):11177-82
9556606
Curr Cancer Drug Targets. 2008 Aug;8(5):359-66
18690842
Science. 2001 Aug 3;293(5531):876-80
11423618
Cancer Res. 2005 Dec 1;65(23):11118-28
16322262
ScientificWorldJournal. 2006 Aug 11;6:918-30
16906325
Mol Cancer Ther. 2008 Mar;7(3):607-15
18347147
J Clin Oncol. 2008 Dec 10;26(35):5705-12
19001320
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2316-21
16461907
Nature. 1989 May 18;339(6221):230-1
2654648
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11755-60
15284443
Cancer Cell. 2002 Feb;1(1):89-97
12086891
J Clin Oncol. 2008 Sep 10;26(26):4268-75
18626007
J Clin Oncol. 2010 Mar 1;28(7):1254-61
20100961
Int J Cancer. 2007 Jan 15;120(2):436-43
17096350
Eur J Haematol. 2007 May;78(5):417-31
17432977
Expert Opin Pharmacother. 2009 Mar;10(4):589-600
19284362
Cancer Cell. 2002 Mar;1(2):117-23
12086869
Cancer. 2008 Apr 15;112(8):1744-53
18338744
Cancer Cell. 2005 Feb;7(2):129-41
15710326
Genes Cancer. 2010 Jan;1(1):12-25
21779425
Blood. 2009 Aug 20;114(8):1607-17
19541823
J Clin Oncol. 2008 May 1;26(13):2228-30; author reply 2230-1
18445856
Cancer Res. 2009 Mar 1;69(5):1851-7
19223544
Curr Opin Genet Dev. 2008 Feb;18(1):73-9
18325754
Int J Med Sci. 2004;1(2):101-115
15912202
Drug Metab Dispos. 2009 Feb;37(2):359-65
18971320
Exp Hematol. 2005 Jul;33(7):767-75
15963852
Blood Cells Mol Dis. 2002 Jan-Feb;28(1):75-85
11987244
J Natl Cancer Inst. 2000 Oct 18;92(20):1641-50
11036109
J Carcinog. 2008;7:9
19240370
Clin Cancer Res. 2009 Sep 1;15(17):5445-56
19706799
CA Cancer J Clin. 2008 Jul-Aug;58(4):231-44
18596196
Nature. 1989 May 11;339(6220):155-6
2541345
Br J Cancer. 2006 Jan 30;94(2):247-52
16404430
Anticancer Agents Med Chem. 2007 Nov;7(6):651-9
18045060
Clin Cancer Res. 2003 Feb;9(2):625-32
12576428
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12085-90
19597153
Eur J Cancer. 2009 May;45(7):1265-1273
19167213
Curr Opin Struct Biol. 2002 Dec;12(6):735-41
12504677
Neoplasia. 2007 Feb;9(2):90-100
17357254
Cancer Res. 2008 Nov 15;68(22):9176-83
19010889
Neoplasia. 2009 May;11(5):448-58, 2 p following 458
19412429
Cancer Cell. 2007 Oct;12(4):395-402
17936563
Anticancer Res. 2001 Jan-Feb;21(1B):601-4
11299812
Cancer Res. 2003 Jan 15;63(2):375-81
12543790
Int J Biochem Cell Biol. 2010 Aug;42(8):1282-90
20083225
Clin Cancer Res. 2006 Aug 1;12(15):4747-54
16899626
Clin Cancer Res. 2007 Mar 1;13(5):1552-61
17332301
Int J Cancer. 2004 Jan 20;108(3):334-41
14648698
Int J Oncol. 1999 Jul;15(1):137-41
10375606
Cancer Lett. 2002 Dec 10;187(1-2):111-9
12359358
Cancer Res. 2008 Dec 1;68(23):9809-16
19047160
Cancer Res. 2006 Apr 15;66(8):3992-5
16618717
Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6205-6; author reply 6206-7
17062700
Cancer Res. 2001 Jun 15;61(12):4744-9
11406546
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7795-800
16682622
Cancer Res. 2009 Apr 1;69(7):3032-41
19318574
Leukemia. 2007 Jul;21(7):1561-2; author reply 1562-4
17429432
Int J Cancer. 2002 Jun 20;99(6):783-91
12115478
Cancer Lett. 2009 Jun 28;279(1):74-83
19232821
Cancer Res. 2005 May 1;65(9):3509-12
15867338
Clin Lung Cancer. 2009 Jul;10(4):281-9
19632948
Cancer Res. 2002 Nov 1;62(21):5995-8
12414617
Cancer Lett. 2009 Oct 8;283(2):125-34
19217204
Oncogene. 2008 Jan 24;27(5):684-93
17684486
Oncologist. 2007 Jun;12(6):719-26
17602061
Cancer Res. 1998 May 1;58(9):1808-12
9581817
Mol Cancer Ther. 2005 Aug;4(8):1167-74
16093432
Blood. 2006 Jan 1;107(1):293-300
16150941
J Clin Invest. 2008 Jul;118(7):2609-19
18568074
Pathol Oncol Res. 2003;9(1):13-9
12704441
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8425-30
8710887
Lancet. 1998 Mar 21;351(9106):882-3
9525374
Int J Cancer. 2010 Oct 15;127(8):1785-94
20099276
PLoS Med. 2005 Jan;2(1):e17
15696205
Cancer Res. 2008 Mar 1;68(5):1471-7
18316611
Endocr Relat Cancer. 2004 Dec;11(4):793-814
15613453
Mol Hum Reprod. 2000 Jun;6(6):529-34
10825370
Mol Pharmacol. 2006 Aug;70(2):589-603
16622074
Mol Carcinog. 2007 Feb;46(2):155-64
17186543
J Clin Oncol. 2009 Apr 1;27(10):1675-84
19255327
Mol Cancer Ther. 2008 Apr;7(4):874-9
18413800
Clin Cancer Res. 1996 Mar;2(3):601-9
9816209
Blood. 2003 Mar 15;101(6):2368-73
12609962
Blood. 2003 May 1;101(9):3597-605
12531805
Mol Cell Biol. 1989 Mar;9(3):1165-72
2566907
Blood. 2006 Jul 15;108(2):697-704
16597591
Nature. 2004 Nov 18;432(7015):294-7
15549090
Arch Pathol Lab Med. 2006 May;130(5):669-79
16683885
J Clin Oncol. 2009 Apr 20;27(12):2091-6
19188670
Blood. 2002 Aug 1;100(3):1014-8
12130516
Nat Rev Cancer. 2009 Jan;9(1):28-39
19104514
Cancer Lett. 2007 May 8;249(2):121-32
16949736
Expert Rev Anticancer Ther. 2008 Sep;8(9):1387-98
18759691
Br J Cancer. 2007 Apr 23;96(8):1166-9
17375050
Cancer Lett. 2010 Jun 1;292(1):54-63
19959278
J Clin Oncol. 2010 Mar 10;28(8):1387-94
20142592
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20932-7
18093943
Oncogene. 2008 Jun 26;27(28):3944-56
18297114
Clin Cancer Res. 2007 Aug 1;13(15 Pt 2):s4606-12
17671150
Clin Cancer Res. 2008 Apr 15;14(8):2465-75
18413839
Oncogene. 2010 Apr 22;29(16):2346-56
20118985
Nature. 2006 Dec 21;444(7122):1083-7
17183323
Cancer Cell. 2003 Apr;3(4):347-61
12726861
J Clin Oncol. 2010 Jan 20;28(3):453-9
20008624
Cancer Res. 2008 Dec 15;68(24):10307-14
19074899
Cancer Cell. 2005 Oct;8(4):299-309
16226705
Int J Oncol. 2007 Nov;31(5):1157-63
17912443
Mol Cancer Ther. 2007 Feb;6(2):667-74
17308062
Clin Pharmacol Ther. 2008 Feb;83(2):258-64
17568400
Am J Health Syst Pharm. 2008 Jan 15;65(2):123-31
18192256
Nat Rev Cancer. 2006 Sep;6(9):714-27
16929325
Nature. 1981 Feb 12;289(5798):607-9
6258087
Curr Opin Drug Discov Devel. 2009 Mar;12(2):246-52
19333870
Cold Spring Harb Symp Quant Biol. 2005;70:419-26
16869779
Leukemia. 2008 Sep;22(9):1806-7
18668129
Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19936-41
18077425
Mol Pharm. 2010 Apr 5;7(2):386-97
20039696
Curr Cancer Drug Targets. 2009 May;9(3):320-40
19442052
Cancer Res. 2007 Sep 1;67(17):8240-7
17804738
J Biol Chem. 1999 Mar 26;274(13):8865-74
10085130
Cell. 1981 Aug;25(2):355-61
6269741
Methods Mol Biol. 2010;596:47-76
19949920
Cell. 2000 Jan 7;100(1):57-70
10647931
Cancer Cell. 2010 Jan 19;17(1):77-88
20129249
Ann Oncol. 2008 Mar;19(3):508-15
17998284
Leukemia. 2004 Aug;18(8):1321-31
15215876
Gynecol Oncol. 2009 May;113(2):249-55
19237188
Oncogene. 2005 Apr 21;24(18):3002-10
15735715
Crit Rev Oncol Hematol. 2004 Apr;50(1):23-38
15094157
Cancer Res. 2010 Feb 15;70(4):1625-34
20124471
Oncologist. 2003;8(6):531-8
14657531
Cancer Lett. 2009 Oct 8;283(2):135-42
19380191
Gynecol Oncol. 2008 Dec;111(3):478-86
18823650
Clin Cancer Res. 2008 Jun 15;14(12):3881-8
18559609
Cancer Res. 2005 Mar 1;65(5):1770-7
15753373
Science. 2007 May 18;316(5827):1039-43
17463250
Cancer Res. 2005 Jun 1;65(11):4500-5
15930265
Cancer Cell. 2004 Aug;6(2):117-27
15324695
N Engl J Med. 2004 May 20;350(21):2129-39
15118073
Cancer Biol Ther. 2009 Apr;8(8):696-703
19276677
Ann Hematol. 2003 May;82(5):284-9
12692682
Nat Med. 2005 Sep;11(9):992-7
16127434
Cancer Lett. 2003 Sep 10;199(1):61-8
12963124
PLoS Med. 2005 Mar;2(3):e73
15737014
Ann Oncol. 2009 Jan;20(1):84-90
18669866
Cancer Res. 2010 Feb 1;70(3):1063-71
20103651
Cancer Res. 2005 Jan 15;65(2):473-82
15695389
Blood. 2004 Dec 1;104(12):3739-45
15315971
Cancer Treat Rev. 2009 Apr;35(2):121-36
19008049
Ann Oncol. 2008 Jun;19(6):1053-9
18304967
Ann Pharmacother. 2006 Feb;40(2):261-9
16418322
J Natl Cancer Inst. 2007 Feb 7;99(3):192-4
17284712
Br J Cancer. 2007 Oct 22;97(8):1139-45
17940504
Int J Cancer. 2010 Jun 15;126(12):2893-903
19856307
Biochemistry. 1987 Mar 10;26(5):1434-42
3494472
Cancer Res. 2008 Nov 15;68(22):9479-87
19010923
Cancer Res. 2007 Mar 1;67(5):2325-30
17332364
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5090-5
16547140
Ann Hematol. 2010 Jul;89(7):653-62
20119833
Cancer Res. 2004 Sep 15;64(18):6385-9
15374944
Cell. 2007 Nov 2;131(3):463-75
17981115
Oncogene. 2000 Nov 20;19(49):5548-57
11114734
Leukemia. 2009 May;23(5):845-51
19212337
Clin Cancer Res. 2006 Sep 1;12(17):5064-73
16951222
Semin Cancer Biol. 2003 Aug;13(4):253-8
14563119
J Clin Invest. 2006 Oct;116(10):2695-706
16906227
J Natl Cancer Inst. 2001 Dec 19;93(24):1852-7
11752009
Br J Cancer. 2007 Mar 26;96(6):857-63
17325698
Oncologist. 2004;9 Suppl 3:1-3
15163840